JPRN-UMIN000005100暂停2 期
A Phase II trial of S-1 and Docetaxel followed by FEC as neoadjuvant chemotherapy for primary breast cancer - A Phase II trial of S-1 and Docetaxel followed by FEC as neoadjuvant chemotherapy for primary breast cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 暂停
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Inflammatory breast cancer and bilateral breast cancer 2) Previous (less than 5 years) or current history of malignant neoplasm 3) Known immediate or delayed hypersensitivity reaction or contraindication to drugs chemically related to any of the study treatment 4) Severe complications (uncontrolled diabetes mellitus, heart failure, interstitial pneumonia or pulmonary fibrosis etc.) 5) Sever bone marrow suppression 6) Renal dysfunction (serum Cre is more than ULN), liver dysfunction ( T-Bil or AST/ALT is more than 2.5 times ULN ) 7) During administration of fluoropyrimidines 8) Active infection (more than 38.0C) 9) During administration of flucytosine, phenytoin, warfarin potassium 10) During administration of pentostatin 11) During pregnancy or lactation 12) Patients judged inappropriate by physicians
研究者
相似试验
已完成
1 期
Phase I/II Study of Docetaxel and S-1 Combination Therapy for Advanced Non-small Cell Lung CancerJPRN-C000000281The Tokyo Cooperative Oncology Group60
已完成
2 期
Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric CancerMetastatic gastric cancer (Advanced or recurrent gastric cancer)JPRN-C000000103Hiroshima Cancer Therapy Development Organization (HiCTDO)50
已完成
2 期
Randomized phase II trial of S-1 plus docetaxel combination versus single-agent docetaxel in platinum-pretreated patients with non-small-cell lung cancerplatinum-pretreated patients with non-small-cell lung cancerJPRN-C000000133Okayama Lung Cancer Study Group60
已完成
3 期
A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric CancerGastric CancerJPRN-C000000251Japan Clinical Cancer Research Organization628
已完成
不适用
A Phase III Study of Docetaxel plus S-1 versus S-1 Alone in the Treatment of Curatively Resected Stage III Gastric CancerGastric CancerJPRN-UMIN000010337Japan Clinical Cancer Reseach Organization (JACCRO)1,100